pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients

Conference name: 2nd International conference on pathology

Short name: Pathology 2019

Venue : Paris,France | July 5-6,2019

URL: https://bit.ly/2GS09CI

A total of 249 candidates were studied to estimate the ability of pretreatment neutrophil-to-lymphocyte ratio (NLR) to predict survival in patients with parotid cancer. They reported a mean NLR of 2.48, with a range from 1.5 to 6.1; intraparotid node metastasis in 18.1% of cases. They found a significant association of NLR with tumor stage, disease stage, and disease grade. They recorded a 10 -year disease-specific survival (DSS) rate of 62%; 73 patients died due to the disease. They found a 10 -year DSS rate of 68% and 58% in the cases with an NLR<2.48 and an NLR≥2.48, respectively, with a significant difference. They observed the NLR as an independent prognostic factor for DSS in the Cox model analysis.

Author: Cheng G 

To know more about Pathology and its Applications do attend International Conference on Pathology 2019 http://pathology.alliedacademies.com/

Contact
KRISTIE NOVA
Program Director | PATHOLOGY 2019
Phone: (44) 20 3769 1755
Email: pathology(at)alliedannualsummit(dot)com